Consumer Driven Innovation for Continuous Glucose Monitoring in Diabetes Patients
Imagine if your life suddenly depended on monitoring your body’s reaction every time you had a snack, skipped a meal, or ate a piece of candy. This is a reality for approximately 1.25 million people in the USA who have been diagnosed with Type 1 Diabetes (T1D).
People with T1D experience unhealthy fluctuations in blood glucose levels due to the destruction of beta cells in the pancreas by the person’s own immune system. Beta cells produce insulin, which is a hormone that allows your body to break down, use, or store glucose, while maintaining a healthy blood sugar level throughout the day. Presently, there is no cure for T1D so patients must be constantly vigilant about maintaining their blood glucose levels within a healthy range in order to avoid potentially deadly consequences.
Currently, continuous glucose monitors (CGMs) are the most effective way to manage T1D. However, consumers have already become frustrated with the limitations of commercially available CGMs, and are developing at-home modifications to overcome them. This in turn, is influencing the direction of research and development in the biomedical devices industry, as multiple companies compete to create a CGM that appeals to the largest consumer population.
Thus, consumer-driven innovation in CGM data access, CGM-insulin pump integration, and glucose sensor lifespan has led to rapid growth in the field of diabetes management devices.
Coping with the Highs and Lows
Patients with T1D need to monitor their blood glucose levels to ensure they don’t become hyperglycemic (high blood glucose levels), or hypo Continue reading